What is the Market's View on Theratechnologies Inc (THTX) Stock's Price and Volume Trends Wednesday?

Overall market sentiment has been high on Theratechnologies Inc (THTX) stock lately. THTX receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Theratechnologies Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on THTX!

See Full THTX Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With THTX Stock Today?

Theratechnologies Inc (THTX) stock is trading at $1.49 as of 10:46 AM on Wednesday, Mar 27, a rise of $0.10, or 7.19% from the previous closing price of $1.39. The stock has traded between $1.42 and $1.49 so far today. Volume today is less active than usual. So far 10,092 shares have traded compared to average volume of 42,689 shares. To screen for more stocks like Theratechnologies Inc click here.

More About Theratechnologies Inc

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Click Here to get the full Stock Report for Theratechnologies Inc stock.